Mario Bustos Rodriguez, MD
Endocrinology, Diabetes & Metabolism · Tulsa, OKNPI 1700265584
Payments from drug & device makers
Across 664 payments — averaging $28.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$3K
- Abbott$3K
- AstraZeneca$2K
- Novo Nordisk$2K
- Boehringer Ingelheim$1K
- Lilly USA, LLC$1K
- plus $6K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 117 | $3,049 |
| Abbott | 77 | $2,643 |
| AstraZeneca(2 entities) | 79 | $2,304 |
| Novo Nordisk | 80 | $1,939 |
| Boehringer Ingelheim | 42 | $1,329 |
| Lilly USA, LLC | 56 | $1,160 |
| Amgen(2 entities) | 34 | $1,041 |
| Bayer | 22 | $855 |
| Insulet Corporation | 18 | $671 |
| Medtronic(2 entities) | 7 | $423 |
| Tandem Diabetes Care, Inc. | 13 | $412 |
| Xeris Pharmaceuticals, Inc. | 15 | $321 |
| Mannkind Corporation | 8 | $296 |
| Neurocrine Biosciences, Inc. | 6 | $248 |
| AbbVie | 15 | $244 |
| Ultragenyx Pharmaceutical Inc. | 9 | $197 |
| Antares Pharma, Inc. | 2 | $151 |
| Corcept Therapeutics | 6 | $148 |
| Astellas Pharma US Inc | 5 | $132 |
| Sanofi-aventis U.S. LLC | 1 | $127 |
| Esperion Therapeutics, Inc. | 6 | $119 |
| BETA Bionics, Inc. | 5 | $116 |
| Chiesi USA, Inc. | 5 | $109 |
| Amarin Pharma, Inc. | 6 | $108 |
| Ascendis Pharma Endocrinology Inc | 4 | $106 |
| Recordati_rare_diseases_inc. | 3 | $70 |
| IBSA Pharma Inc. | 3 | $63 |
| Currax Pharmaceuticals LLC | 4 | $59 |
| Amryt Pharma Holdings Ltd | 3 | $56 |
| Novartis | 2 | $38 |
| OPKO Pharmaceuticals, LLC | 2 | $36 |
| Nevro Corp. | 2 | $36 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Rhythm Pharmaceuticals, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Intra-sana Laboratories | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
How this compares
$18,742 in reported general payments places this provider in the 80th percentile of 61 endocrinology, diabetes & metabolism providers in Oklahoma.
See all endocrinology, diabetes & metabolism providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Tulsa
- Cristin BrunsTulsa$159K
- Donald AspensonTulsa$153K
- Elie AbedTulsa$27K
- Hanna FoggTulsa$25K
- Lauren LabryerTulsa$12K
- Vishnu Priya PulipatiTulsa$8K
- Maria VargasTulsa$7K
- Christian HansonTulsa$4K
- Miguel Jara PalaciosTulsa$4K
- Deepa PhilipTulsa$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.